Mark Jeakle

Also affiliated with National Institutes of Health Clinical Center

MedicineEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Nicotinamide Antagonizes Lipopolysaccharide-Induced Hypoxic Cell Signals in Human Macrophages”.

Nicotinamide Antagonizes Lipopolysaccharide-Induced Hypoxic Cell Signals in Human Macrophages

The Journal of Immunology(2023)10.4049/jimmunol.2200552

N/A

0DataRank · unranked

11 citations

Edward J. Dougherty, Xizhong Cui, Yan Li, Mark Jeakle, T. Gamble +3 more

Anti-PD-L1 therapy altered inflammation but not survival in a lethal murine hepatitis virus-1 pneumonia model

Frontiers in Immunology(2024)10.3389/fimmu.2023.1308358

N/A

0DataRank · unranked

3 citations

Xizhong Cui, Yan Li, Mark Jeakle, Junfeng Sun, Cumhur Y. Demirkale +9 more

A systematic review of adult animal models investigating ECMO use for ARDS: where to from here

Intensive Care Medicine Experimental(2025)10.1186/s40635-025-00781-5

N/A

0DataRank · unranked

1 citations

Xizhong Cui, Mark Jeakle, Yan Li, Nancy Terry, T. Gamble +5 more